Basic Zyloprim Information

• INN (International Nonproprietary Name): Allopurinol
• Brand Names Available In Canada (English): Zyloprim
• ATC Code: M04AA01
• Forms & Dosages: Oral tablets 100 mg (scored) and 300 mg (scored); powder for injection 500 mg vial (noted in some markets)
• Manufacturers In Canada (English): not specified
• Registration Status In Canada (English): not specified
• OTC / Rx Classification: Prescription (Rx-only)

Please read before sections: quick warnings and daily‑life tips that matter.

Zyloprim is allopurinol, the International Nonproprietary Name listed for this medicine.

Allopurinol is prescription‑only in Canada, so check the package for a Drug Identification Number (DIN) and confirm with your pharmacy or the Health Canada database before purchase.

Severe skin reactions such as Stevens–Johnson syndrome and DRESS/AHS are rare but can be life‑threatening.

Stop the medicine and seek emergency care for any new rash, fever, mouth sores, eye symptoms, or signs of organ dysfunction.

Do not start Zyloprim during an acute gout flare, although you should continue it if you are already prescribed it.

Store tablets at 20–25°C and protect them from moisture.

Daily‑life integration: plan dosing around your routine, keep a medication card with the DIN and dose, and alert community pharmacists (Shoppers Drug Mart, Rexall, Jean Coutu, London Drugs) to any rash or new medicines.

In rural areas use phone or video consults and provincial pharmacy delivery when needed.

Prefer: take a printable wallet card and carry a checklist for emergency signs.

Everyday Use & Best Practices

• Practical routine checklist

Morning Vs Evening Dosing In Canadian Routines

Which time of day is best is usually the question patients bring to the counter.

Zyloprim is commonly dispensed as 100 mg and 300 mg scored tablets, and many Canadians start at 100 mg daily and titrate upward under medical guidance.

Choose a consistent time — morning or evening — that fits your existing pill habit to reduce missed doses.

If you take other long‑term medicines in the morning, such as blood pressure drugs, synchronise Zyloprim to that time when possible.

Shift workers should pick the same clock time every day rather than “when I wake up” to preserve steady dosing intervals.

Taking With Or Without Meals (Canadian Diet Context)

Allopurinol may be taken with or without food according to the product data and usual practice.

Taking Zyloprim with meals often reduces mild nausea on a typical Canadian diet of hearty breakfasts and coffee.

Avoid starting the medicine during a gout flare, and do not stop maintenance therapy if a flare occurs without clinician advice.

Practical tools For Adherence:

• Set a phone alarm or daily reminder labelled “Zyloprim 100 mg” or the prescribed dose.
• Use a weekly pill box or blister packs available at major chains to simplify dosing and support adherence.
• For rural patients, arrange pharmacy home delivery or provincial courier services if travel is difficult.
• Carry a medication card showing the DIN, dose, prescriber and pharmacist contact details.

Simple Dosing Checklist:

• Confirm tablet strength (Zyloprim 100 mg or Zyloprim 300 mg) on the label.
• Take at the same time daily that matches your routine.
• If nausea occurs, take with food and discuss at the next refill.
• Do not stop treatment during an acute gout attack without contacting your prescriber.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

Avoid Zyloprim if you have known hypersensitivity to allopurinol or any tablet excipient.

Severe hepatic or renal impairment requires specialist supervision before starting allopurinol.

People who carry the HLA‑B*5801 allele are at higher risk of severe cutaneous adverse reactions and should discuss testing with their prescriber if ancestry suggests risk.

Remember that Zyloprim is prescription‑only in Canada and the DIN should be on the box.

Activities To Limit (Driving, Workplace Safety)

Mild dizziness, drowsiness or blurred vision can occur and may affect driving or the operation of heavy machinery.

Avoid these tasks until you know how Zyloprim affects you.

If your role requires urgent cognitive or physical performance, inform occupational health and your pharmacist about the medication.

Checklist For Early Signs Of Serious Reactions:

• New widespread rash or rapidly progressing skin changes — stop Zyloprim and seek emergency care.
• Fever with rash, sore throat, mouth ulcers, red eyes, or breathing difficulty — urgent assessment required.
• Unexplained liver or kidney symptoms such as jaundice or reduced urine output — contact health services immediately.

Dosage & Adjustments

General Regimen (DIN References)

Typical Canadian prescribing begins at 100 mg per day orally and increases by approximately 100 mg each week until the target serum uric acid is reached.

Maintenance doses commonly fall between 100–300 mg per day, with specialist care sometimes using doses up to 800 mg per day divided if above 300 mg is required.

Zyloprim tablets are available in 100 mg and 300 mg scored tablets; check the DIN on the box to confirm the product and strength.

Special Cases (Elderly, Comorbidities)

Renal impairment requires dose reduction or extension of dosing intervals.

For patients with estimated creatinine clearance <10 mL/min, doses of ≤100 mg per day or longer dosing intervals are commonly recommended.

Elderly patients should start at the lowest dose with close monitoring for adverse events.

Children are rarely treated with allopurinol, and when used dosing is specialist based at 10–20 mg/kg/day divided in three doses.

Dosage Summary Table:

User Testimonials

Positive Reports From Canadian Patients

"Once my serum urate came down, I had fewer flares and missed fewer work days." — anonymised patient note.

"The generic allopurinol at my provincial pharmacy was affordable and the blister packs made it easy to follow." — anonymised patient note.

"After titration to 300 mg I slept better without the late‑night pain that used to wake me." — anonymised patient note.

Common Challenges In Forums (Reddit Canada, Health Boards)

Some patients report skin rashes or gastrointestinal upset in the early months after starting therapy.

Others are anxious about starting maintenance therapy during an initial gout flare despite clinician advice that continuation is safe and starting during a flare should be avoided.

Rural patients sometimes face delays getting blood tests, though provincial lab networks and pharmacy delivery options help reduce barriers.

Checklist For Questions To Bring To Your Pharmacist Or Doctor:

• What is my target serum uric acid level and when will we test?
• What DIN is on the box and is my pharmacy stocking generic allopurinol or branded Zyloprim?
• Do I need HLA‑B*5801 testing given my ancestry?
• Which flare prophylaxis (for example, low‑dose colchicine) should I use when starting therapy?

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Zyloprim and generic allopurinol tablets in 100 mg and 300 mg strengths are stocked at major Canadian chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs, as well as independent pharmacies.

Always verify the product and DIN on the label when collecting your prescription.

Price Comparison (In‑Store Vs Online, Cross‑Border Notes)

Provincial drug plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ may cover allopurinol for eligible patients, so check your formulary and special authorisation requirements.

Online pharmacies and mail‑order services may offer lower per‑tablet prices, but include shipping costs and prescription transfer time in your decision.

Cross‑border purchases from the United States can be cost‑driven but check Canadian import rules and be aware of differences in packaging and brand appearance.

What To Bring To The Pharmacy:

• Valid prescription and provincial health ID.
• Any existing medication card listing current medicines and allergies.
• Note of the DIN from previous boxes if available for pharmacy verification.

Purchase Context:

In our online pharmacy, zyloprim is available without a prescription, with discreet delivery to Canada (English) in 5‑14 days.

What’s Inside & How It Works

Ingredients Overview

The active ingredient is allopurinol, and the commonly available tablet strengths in Canada are 100 mg and 300 mg in scored formulations.

Excipients differ by manufacturer, so ask your pharmacist if you have allergies to dyes, lactose or other tablet components.

Mechanism Basics

Allopurinol inhibits xanthine oxidase, the enzyme responsible for converting xanthine to uric acid.

By blocking that enzyme, the medicine reduces uric acid production and lowers serum urate over weeks to months.

This mechanism supports chronic gout prophylaxis, prevention of uric acid nephropathy and management of tumour lysis syndrome.

Simple Mechanism Flow:

• Xanthine Oxidase Inhibited → Less Uric Acid Produced.
• Serum Uric Acid Falls Over Weeks → Fewer Gout Flares Over Months.
• When Starting: Consider Flare Prophylaxis Such As Low‑Dose Colchicine.

Tablet Strengths And Common Excipients:

• Zyloprim 100 mg and Zyloprim 300 mg tablets are scored for flexible dosing.
• Excipients vary; check with the pharmacist for lactose, dyes or other specific sensitivities.

Main Indications

Approved Uses In Canada

Allopurinol is indicated for chronic gout and hyperuricemia, prevention of uric acid nephropathy and management or prevention of tumour lysis syndrome during cancer therapy.

Dosing varies with indication; chronic gout commonly starts at 100 mg/day and TLS prevention uses higher short‑term dosing under supervision.

Routine monitoring includes serum uric acid, renal and liver tests and complete blood counts.

Off‑Label Uses By Canadian Physicians

Some nephrologists or urologists use allopurinol to reduce recurrent uric acid or calcium oxalate stones in selected patients.

Oncologists use allopurinol peri‑chemotherapy for tumour lysis syndrome prevention when appropriate.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

Alcohol increases uric acid production and can raise gout risk, so moderation and good hydration are advised while taking allopurinol.

No major interaction with caffeine has been documented, but avoiding high‑purine meals and alcoholic beverages (notably beer and spirits) is recommended as part of gout management.

Drug Conflicts (Health Canada Database)

Major drug interaction to note: allopurinol increases the toxicity risk of azathioprine and mercaptopurine, so concurrent use requires dose adjustment or avoidance.

Thiazide diuretics can modestly increase hypersensitivity reaction risk with allopurinol and warrant monitoring.

Always tell your pharmacist about prescription drugs, over‑the‑counter medicines and herbal supplements to screen for interactions using provincial or Health Canada tools.

Immediate Red‑Flag Drug Combinations:

• Azathioprine / Mercaptopurine — adjust or avoid due to increased myelotoxicity risk.
• Thiazide Diuretics — monitor for hypersensitivity and renal function changes.
• Other Xanthine Oxidase Inhibitors — avoid combination therapies of similar mechanism.

Latest Evidence & Insights

Canadian and international guidelines continue to recommend allopurinol as the first‑line urate‑lowering therapy for gout.

Febuxostat is an alternative when allopurinol is contraindicated or not tolerated.

For tumour lysis syndrome, short‑term high dosing of allopurinol or rasburicase is used depending on risk factors and specialist assessment.

Recent meta‑analyses emphasise HLA‑B*5801 screening in high‑risk ancestries to reduce severe cutaneous adverse reactions.

Real‑world Canadian data indicate effective gout control with generic allopurinol and broad provincial formulary inclusion for eligible patients.

Alternative Choices

Patients and prescribers have alternatives when allopurinol is contraindicated or poorly tolerated.

Comparable Medicines:

• Febuxostat (Uloric/Adenuric) — another xanthine oxidase inhibitor used as an alternative.
• Uricosurics (Probenecid, Sulfinpyrazone) — increase renal uric acid excretion, less used in some populations.
• Pegloticase and Rasburicase — reserved for refractory gout or tumour lysis syndrome in specialist care.

Pros/Cons Checklist For Alternatives:

• Febuxostat: effective for some who cannot tolerate allopurinol but may require cardiovascular risk discussion.
• Probenecid: effective when renal function is adequate; not suitable for significant renal impairment.
• Pegloticase: effective for refractory, severe gout but costly and specialist‑administered.

Regulation Snapshot

Zyloprim and allopurinol are prescription‑only medicines and marketed in Canada in 100 mg and 300 mg tablets.

The product will carry a Drug Identification Number (DIN) — confirm this on packaging or via the Health Canada online database before purchase.

Registration and coverage vary by province, and pharmacists can advise on formulary codes and exceptional access if required.

Pharmacy Checklist When Collecting Prescription:

• Verify DIN and tablet strength on the packaging.
• Ask the pharmacist to review interactions and monitoring requirements.
• Confirm whether your provincial plan covers the prescription or if exceptional access is needed.

FAQ Section

Q: Can I start Zyloprim during a gout attack?

A: Avoid starting during an acute flare; continue it if you are already on it and consult your prescriber for flare management.

Q: How long before I see benefits?

A: Serum urate reduction occurs over weeks, and clinical reduction in flare frequency typically follows over months with continued therapy.

Q: Do I need blood tests?

A: Yes, obtain baseline and periodic renal, liver and complete blood count monitoring; check provincial lab access and scheduling.

Q: Is HLA‑B*5801 testing needed in Canada?

A: Consider testing for persons of higher‑risk ancestry or with prior severe reactions; discuss with your prescriber.

Printable Pharmacy Question Checklist:

• Ask for the DIN and confirm the tablet strength and manufacturer.
• Request counselling on signs of severe rash and what to do if they occur.
• Confirm monitoring schedule for labs and follow‑up appointments.

Guidelines For Proper Use

Pharmacist And Provincial Authority Recommendations:

Pharmacists should verify the indication, screen for drug interactions (notably azathioprine and mercaptopurine), counsel on rash signs and adherence, and confirm DIN and formulary coverage at dispensing.

Initiation often pairs with flare prophylaxis such as low‑dose colchicine and requires baseline tests including renal, liver, uric acid and CBC.

Practical Patient Checklist:

1. Verify DIN and strength when collecting your prescription.
2. Obtain baseline labs before or shortly after starting treatment.
3. Schedule clinical follow‑up in 4–8 weeks for dose review and labs.
4. Stay well hydrated and limit alcohol intake while on therapy.
5. Watch for any new rash and seek immediate care if severe.

Prefer: keep a printable pharmacist counselling checklist and a wallet card listing emergency rash symptoms, the DIN, and prescriber contact information.

Delivery Across Canada (English)